Milo R - Search Results

1

Immunological Aspects of Approved MS Therapeutics.

Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O. Rommer PS, et al. Among authors: milo r. Front Immunol. 2019 Jul 11;10:1564. doi: 10.3389/fimmu.2019.01564. eCollection 2019. Front Immunol. 2019. PMID: 31354720 Free PMC article. Review.

2

Translational research in neurology and neuroscience 2010: multiple sclerosis.

Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, Khan O, Eagar TN. Stüve O, et al. Among authors: milo r. Arch Neurol. 2010 Nov;67(11):1307-15. doi: 10.1001/archneurol.2010.158. Epub 2010 Jul 12. Arch Neurol. 2010. PMID: 20625066 Free PMC article. Review.

3

The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors.

Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O. Sellner J, et al. Among authors: milo r. Autoimmun Rev. 2011 Jun;10(8):495-502. doi: 10.1016/j.autrev.2011.02.006. Epub 2011 Feb 24. Autoimmun Rev. 2011. PMID: 21354338

4

Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review.

Awad AM, Marder E, Milo R, Stüve O. Awad AM, et al. Among authors: milo r. Ther Adv Neurol Disord. 2011 Jul;4(4):231-5. doi: 10.1177/1756285611405565. Ther Adv Neurol Disord. 2011. PMID: 21765873 Free PMC article.

5

Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs.

Milo R. Milo R. Expert Opin Pharmacother. 2015 Apr;16(5):659-73. doi: 10.1517/14656566.2015.1002769. Epub 2015 Jan 13. Expert Opin Pharmacother. 2015. PMID: 25582634 Review.

6

Therapeutic strategies targeting B-cells in multiple sclerosis.

Milo R. Milo R. Autoimmun Rev. 2016 Jul;15(7):714-8. doi: 10.1016/j.autrev.2016.03.006. Epub 2016 Mar 9. Autoimmun Rev. 2016. PMID: 26970489 Review.

7

Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis.

Osherov M, Milo R. Osherov M, et al. Among authors: milo r. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1037-1047. doi: 10.1080/17512433.2017.1366854. Epub 2017 Aug 22. Expert Rev Clin Pharmacol. 2017. PMID: 28803486 Review.

8

Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.

Nitsan Z, Kucuk N, Appel S, Tichmanovich N, Osherov M, Milo R. Nitsan Z, et al. Among authors: milo r. J Clin Neurosci. 2018 Feb;48:102-103. doi: 10.1016/j.jocn.2017.10.077. Epub 2017 Nov 3. J Clin Neurosci. 2018. PMID: 29108666

9

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis.

Milo R, Stüve O. Milo R, et al. Degener Neurol Neuromuscul Dis. 2016 Nov 17;6:95-109. doi: 10.2147/DNND.S85747. eCollection 2016. Degener Neurol Neuromuscul Dis. 2016. PMID: 30050372 Free PMC article. Review.

10

[MULTIPLE SCLEROSIS THERAPY - 2019].

Milo R, Karussis D. Milo R, et al. Harefuah. 2019 Jun;158(6):388-394. Harefuah. 2019. PMID: 31215192 Review. Hebrew.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page